Normal versus Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Potential Randomized Examine.
Biomed Res Int. 2017;2017:7236970
Authors: Serban D, Calina N, Tender G
Symptomatic spondylolisthesis sufferers could profit from surgical decompression and stabilization. The usual (S) method is a transforaminal lumbar interbody fusion (TLIF). Newer, minimally invasive (MI) methods appear to supply related outcomes with much less morbidity. We enrolled sufferers with not less than 6 months of signs and image-confirmed low-grade spondylolisthesis, at a single educational establishment, between 2011 and 2015. The sufferers had been randomized to both S or MI TLIF. The first consequence measure was the Oswestry Incapacity Index (ODI) enchancment at 1 12 months. Secondary consequence measures included size of operation, estimated blood loss, size of hospitalization, and fusion charges at 1 12 months. Forty sufferers had been enrolled in every group. The variations in imply operative time and estimated blood loss weren’t statistically important between the 2 teams. The sufferers had been discharged after surgical procedure at four.12 days for the S TLIF group and 1.92 days for the MI TLIF group. The ODI enchancment was related and statistically important in each teams. The fusion was thought of strong in 36 (90%) of sufferers at 1 12 months in each teams. In conclusion, the 2 methods supplied related scientific and radiological outcomes at 1 12 months. The sufferers present process MI TLIF had a shorter hospital keep. This trial is registered with NCT03155789.
PMID: 28698876 [PubMed – indexed for MEDLINE]